Relationship between serum homocysteine, fibrinogen, lipoprotein-a level, and peripheral arterial disease: a dose–response meta-analysis

[1] Fowkes FGR(2013)Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis Lancet 382 1329-1340

[2] Rudan D(2015)Epidemiology of peripheral artery disease Circ Res 116 1509-1526

[3] Rudan I(2017)Peripheral artery disease prevalence and incidence estimated from both outpatient and inpatient settings among medicare fee-for-service beneficiaries in the atherosclerosis risk in communities (ARIC) study JAHA 6 e003796-227

[4] Criqui MH(2020)The year in cardiology: aorta and peripheral circulation. The year in cardiology 2019 Cardiol Croat. 15 214-432

[5] Aboyans V(2018)Peripheral arterial disease Heart Lung Circ 27 427-743

[6] Kalbaugh CA(2004)Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999–2000 Circulation 110 738-1539

[7] Kucharska-Newton A(2015)Pathogenesis of the limb manifestations and exercise limitations in peripheral artery disease Circ Res 116 1527-97

[8] Wruck L(2011)Exercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefits Circulation 123 87-512

[9] Heiss C(1996)Quality of life in patients with intermittent claudication Eur J Vasc Endovasc Surg 12 511-1160

[10] Pitcher A(2017)2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS) Kardiol Pol 75 1065-85

[1] Fowkes FGR(2013)Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis Lancet 382 1329-1340

[2] Rudan D(2015)Epidemiology of peripheral artery disease Circ Res 116 1509-1526

[3] Rudan I(2017)Peripheral artery disease prevalence and incidence estimated from both outpatient and inpatient settings among medicare fee-for-service beneficiaries in the atherosclerosis risk in communities (ARIC) study JAHA 6 e003796-227

[4] Criqui MH(2020)The year in cardiology: aorta and peripheral circulation. The year in cardiology 2019 Cardiol Croat. 15 214-432

[5] Aboyans V(2018)Peripheral arterial disease Heart Lung Circ 27 427-743

[6] Kalbaugh CA(2004)Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999–2000 Circulation 110 738-1539

[7] Kucharska-Newton A(2015)Pathogenesis of the limb manifestations and exercise limitations in peripheral artery disease Circ Res 116 1527-97

[8] Wruck L(2011)Exercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefits Circulation 123 87-512

[9] Heiss C(1996)Quality of life in patients with intermittent claudication Eur J Vasc Endovasc Surg 12 511-1160

[10] Pitcher A(2017)2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS) Kardiol Pol 75 1065-85